- Home
- BCDA vs LFWD Comparison
BCDA vs LFWD Comparison
Compare BCDA & LFWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCDA
- LFWD
- Stock Information
- Founded
- BCDA N/A
- LFWD 2001
- Country
- BCDA United States
- LFWD Israel
- Employees
- BCDA N/A
- LFWD N/A
- Industry
- BCDA Biotechnology: Pharmaceutical Preparations
- LFWD
- Sector
- BCDA Health Care
- LFWD
- Exchange
- BCDA Nasdaq
- LFWD NYSE
- Market Cap
- BCDA 10.1M
- LFWD 10.5M
- IPO Year
- BCDA N/A
- LFWD 2014
- Fundamental
- Price
- BCDA $2.35
- LFWD $0.78
- Analyst Decision
- BCDA Strong Buy
- LFWD Strong Buy
- Analyst Count
- BCDA 1
- LFWD 3
- Target Price
- BCDA $25.00
- LFWD $9.00
- AVG Volume (30 Days)
- BCDA 238.1K
- LFWD 807.1K
- Earning Date
- BCDA 08-12-2025
- LFWD 08-14-2025
- Dividend Yield
- BCDA N/A
- LFWD N/A
- EPS Growth
- BCDA N/A
- LFWD N/A
- EPS
- BCDA N/A
- LFWD N/A
- Revenue
- BCDA $3,000.00
- LFWD $25,414,000.00
- Revenue This Year
- BCDA N/A
- LFWD $12.04
- Revenue Next Year
- BCDA N/A
- LFWD $40.58
- P/E Ratio
- BCDA N/A
- LFWD N/A
- Revenue Growth
- BCDA N/A
- LFWD 41.92
- 52 Week Low
- BCDA $1.63
- LFWD $0.50
- 52 Week High
- BCDA $4.66
- LFWD $4.77
- Technical
- Relative Strength Index (RSI)
- BCDA 54.75
- LFWD 43.98
- Support Level
- BCDA $2.22
- LFWD $0.70
- Resistance Level
- BCDA $2.42
- LFWD $0.84
- Average True Range (ATR)
- BCDA 0.13
- LFWD 0.07
- MACD
- BCDA 0.01
- LFWD 0.03
- Stochastic Oscillator
- BCDA 72.97
- LFWD 44.88
About BCDA BioCardia Inc.
BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being advanced for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an off the shelf cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).
About LFWD REWALK ROBOTICS LTD
Lifeward Ltd is a medical device company that designs, develops, and commercializes life-changing solutions that span the continuum of care in physical rehabilitation and recovery, delivering functional and health benefits in clinical settings as well as in the home and community. Its product offerings are the ReWalk Exoskeleton, the ReStore Exo-Suit, the MyoCycle FES bikes, and AlterG Anti-Gravity systems. It operates through markets in the United States, Israel, and Germany.